Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ansari, Adnan Ahmad | - |
dc.contributor.author | Park, Inkeun | - |
dc.contributor.author | Kim, Inki | - |
dc.contributor.author | Park, Sojung | - |
dc.contributor.author | Ahn, Sung-Min | - |
dc.contributor.author | Lee, Jae-Lyun | - |
dc.date.available | 2020-02-27T08:42:59Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2018-10-03 | - |
dc.identifier.issn | 1755-8794 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3197 | - |
dc.description.abstract | Background: Bladder cancer has numerous genomic features that are potentially actionable by targeted agents. Nevertheless, both pre-clinical and clinical research using molecular targeted agents have been very limited in bladder cancer. Results: We created the Genomics of Drug Sensitivity in Bladder Cancer (GDBC) database, an integrated database (DB) to facilitate the genomic understanding of bladder cancer in relation to drug sensitivity, in order to promote potential therapeutic applications of targeted agents in bladder cancer treatment. The GDBC database contains two separate datasets: 1) in-house drug sensitivity data, in which 13 targeted agents were tested against 10 bladder cancer cell lines; 2) data extracted and integrated from public databases, including the Cancer Therapeutics Research Portal, Cancer Cell Line Encyclopedia, Genomics of Drug Sensitivity in Cancer, Kyoto Encyclopedia of Genes and Genomes, and the Cancer Gene Census databases, as well as bladder cancer genomics data and synthetic lethality/synthetic dosage lethality connections. Conclusions: GDBC is an integrated DB of genomics and drug sensitivity data with a specific focus on bladder cancer. With a user-friendly web-interface, GDBC helps users generate genomics-based hypotheses that can be tested experimentally using drugs and cell lines included in GDBC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.relation.isPartOf | BMC MEDICAL GENOMICS | - |
dc.subject | COMPREHENSIVE MOLECULAR CHARACTERIZATION | - |
dc.subject | INHIBITOR | - |
dc.title | Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000446356500001 | - |
dc.identifier.doi | 10.1186/s12920-018-0406-2 | - |
dc.identifier.bibliographicCitation | BMC MEDICAL GENOMICS, v.11 | - |
dc.identifier.scopusid | 2-s2.0-85054403455 | - |
dc.citation.title | BMC MEDICAL GENOMICS | - |
dc.citation.volume | 11 | - |
dc.contributor.affiliatedAuthor | Park, Inkeun | - |
dc.contributor.affiliatedAuthor | Ahn, Sung-Min | - |
dc.type.docType | Article; Data Paper | - |
dc.subject.keywordAuthor | Bladder cancer | - |
dc.subject.keywordAuthor | Database | - |
dc.subject.keywordAuthor | Drug response | - |
dc.subject.keywordAuthor | Pharmacogenomics | - |
dc.subject.keywordAuthor | Therapeutic biomarker | - |
dc.subject.keywordPlus | COMPREHENSIVE MOLECULAR CHARACTERIZATION | - |
dc.subject.keywordPlus | INHIBITOR | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.